David Bonderman
QuietNamed in filings at Rise
- Board seats filed
- 4
- Named on a board
- 0
all filings on record
last 24 months
Named in filings at Rise
all filings on record
last 24 months
from a verified or cited source
| Allogene Therapeutics | Biotech & pharma | April 2018 | Rise Fund Personnel, TPG Healthcare Partners, TPG Personnel, Vida Ventures |
| TPG Valley | Not yet classified | December 2015 | Rise Fund Personnel, TPG Healthcare Partners, TPG Personnel |
| Kite Pharma | Biotech & pharma | April 2014 | TPG Healthcare Partners, TPG Personnel, Vida Ventures |
| Uber Technologies | Mobility & transportation | February 2014 | Benchmark, TPG Healthcare Partners, TPG Personnel |
The company and date are what the SEC filing shows, not a statement of investment thesis. A partner can sit on a board for reasons that say nothing about what their firm funds today. The sector is not a filing value: it is Lev’s own classification of each company, shown only when we found a specific, checkable source for it; otherwise it reads “Not yet classified.” “Also on the board from” names another tracked firm with a partner on the same board, both with a clean identity match. It is not a claim either firm led or co-led the round, and “None on file” means no other tracked firm’s partner shares this specific board seat, not that no one else invested. Sorted newest first by default; click a column to change it. Something wrong? Tell us.
Classified sectors of companies where filings name David Bonderman on the board, based on 3 filed seats with a verified or cited source.
1 more filed seat not yet classified, left out of the shares above.